Health
Research reveals underperformance of many Phase III oncology trials – News-Medical.Net
New research in the September 2021 issue of JNCCN-;Journal of the National Comprehensive Cancer Network finds that more than…
New research in the September 2021 issue of JNCCN-;Journal of the National Comprehensive Cancer Network finds that more than 80% of therapies tested in Phase III oncology trials did not achieve meaningful clinical benefit in prolonging survival. The researchers…
Continue Reading
-
Noosa News22 hours agoBrisbane man charged with arson and attempted murder after violent house fire at Wynnum West
-
Business24 hours agoWhen is ASX AGM season, and what to expect this year?
-
Business16 hours ago3 perfect ASX ETFs for beginners
-
Noosa News21 hours agoAI a ‘strategic necessity’ law lecturer says – Proctor